IFN-ß mediates the anti-osteoclastic effect of bisphosphonates and dexamethasone.

Kalkar, Prajakta; Cohen, Gal; Tamari, Tal; Schif-Zuck, Sagie; Zigdon-Giladi, Hadar; Ariel, Amiram

Kalkar, Prajakta; Cohen, Gal; Tamari, Tal; Schif-Zuck, Sagie; Zigdon-Giladi, Hadar; Ariel, Amiram.

Afiliación

Kalkar P; Departments of Biology and Human Biology, University of Haifa, Haifa, Israel.
Cohen G; Departments of Biology and Human Biology, University of Haifa, Haifa, Israel.
Tamari T; Laboratory for Bone Repair, Rambam Health Care Campus, Haifa, Israel.
Schif-Zuck S; Laboratory for Bone Repair, Rambam Health Care Campus, Haifa, Israel.
Zigdon-Giladi H; The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Ariel A; Departments of Biology and Human Biology, University of Haifa, Haifa, Israel.

Front Pharmacol ; 13: 1002550, 2022.

Article en En | MEDLINE | ID: mdl-36386129

Palabras clave

IFN-ß; dexamethasone; macrophages; multiple myeloma; osteoclast differentiation; resolution of inflammation; zoledronic acid

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google